For Immediate Release
Contact: Lisa Finger, 919-933-2021,lfinger@biosignia.com

BioSignia Board Elects Chairman

July 26, 2011 -- BioSignia today announced the election of E. B. Chester as Chairman of the Board of Directors of BioSignia. He was elected by unanimous vote of the Directors at its recent quarterly meeting in Raleigh, NC.
Mr. Chester joined the Board of Directors of BioSignia in January of 2011 and has had an immediate impact on the commercialization of BioSignia’s technologies. “I am proud to be the Chairman of the Board of Directors of an organization that is poised to become a market leader in several industries. It’s an honor,” said Chester.
Mr. Chester’s business experience includes ownership and executive management of privately and publically owned businesses in Manufacturing, Cable Television, Outdoor Advertising, Banking, Real Estate Aviation Services and Power sports. Currently he and his family are one of the larger group owners of Harley-Davidson dealerships in the United States.
“E. B. Chester has been a valuable member of our Board of Directors,” said John A. Williams, President and CEO of BioSignia. “His background in finance and sales is a tremendous resource and BioSignia is privileged to have someone with his experience leading our Board.”
Mr. Chester lives in Beaver Creek, Colorado and Paradise Valley, Arizona. He will become an active member of BioSignia’s leadership.
For more information on BioSignia, please call 888.324.6627 or email information@biosignia.com.

# # #

About BioSignia

Headquartered in Research Triangle Park, NC, BioSignia is a leading technology company focused on bringing innovative assessment solutions to the preventive health and life insurance markets. At the core of BioSignia’s solutions is the company’s proprietary synthesis modeling approach to morbidity and mortality assessment. In 2004, Biosignia received the Disease Management Association of America’s prestigious award for Best Enabling Tool for Disease Management. Since then, the company’s talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective disease and mortality assessment. BioSignia’s technologies are currently being used by hospital systems, health and wellness organizations, disease management, clinical laboratories, and life insurance organizations. In early 2010, BioSignia partnered with NBC’s The Biggest LoserŪ to provide its advanced health assessment to contestants and viewers. For more information, visit, www.biosignia.com.
BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627